Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MilliporeSigma Enters Three-Way Collaboration | Contract Pharma
Breaking News, Collaborations & Alliances

MilliporeSigma Enters Three-Way Collaboration

With IPS and G-CON Manufacturing

MilliporeSigma announced a collaboration with IPS (Integrated Project Services) and G-CON Manufacturing. The deal will extend MilliporeSigma’s BioReliance End-to-End offering by integrating MilliporeSigma’s single-use process equipment, end-to-end process development capabilities and cGMP manufacturing experience into the iCON facility design platform.

 

“Biologics are helping to fight some of the toughest diseases worldwide, and demand for these therapies continues to grow,” said Andrew Bulpin, head of Process Solutions at MilliporeSigma. “This collaboration is an innovative concept built upon MilliporeSigma’s years of experience in designing, constructing and running cGMP biologics production, combined with the iCON facility, team and design platform. It will decrease time-to-market and accelerate access to biologics to improve the lives of patients around the world.”

 

The integrated offering will deliver a platform for fast and flexible deployment of 2,000L MAb production facilities. The hallmarks of the combined solution will include pre-fabricated cleanroom units, a structural platform based on cost-effective pre-engineered building delivery, bioprocess and single-use equipment expertise, as well as turnkey facilities capable of fast-track deployment.

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters